NCT04387084 2026-03-23
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
University of Southern California
Phase 1 Active not recruiting
University of Southern California
GlaxoSmithKline
Tesaro, Inc.
University of Washington
GlaxoSmithKline
Washington University School of Medicine
Tesaro, Inc.
GlaxoSmithKline